Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.

<h4>Introduction</h4>Coronavirus disease 2019 (COVID-19) appeared in China in December 2019 and has spread around the world. High Interleukin-6 (IL-6) levels in COVID-19 patients suggest that a cytokine storm may play a major role in the pathophysiology and are considered as a relevant p...

Full description

Bibliographic Details
Main Authors: Julie Gorham, Anthony Moreau, Francis Corazza, Lorenzo Peluso, Fanny Ponthieux, Marta Talamonti, Antonio Izzi, Carole Nagant, Narcisse Ndieugnou Djangang, Alessandra Garufi, Jacques Creteur, Fabio Silvio Taccone
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0244628

Internet

https://doi.org/10.1371/journal.pone.0244628

Similar Items